These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2860441)

  • 1. Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients.
    MacMahon SW; Macdonald GJ; Bernstein L; Andrews G; Blacket RB
    Lancet; 1985 Jun; 1(8440):1233-6. PubMed ID: 2860441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of high blood pressure in overweight patients.
    MacMahon S; Macdonald G
    Nephron; 1987; 47 Suppl 1():8-12. PubMed ID: 2962005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of weight reduction and metoprolol in the treatment of hypertension in young overweight patients.
    MacMahon SW; Macdonald GJ; Bernstein L; Andrews G; Blacket RB
    Clin Exp Pharmacol Physiol; 1985; 12(3):267-71. PubMed ID: 3896595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients.
    MacMahon SW; Wilcken DE; Macdonald GJ
    N Engl J Med; 1986 Feb; 314(6):334-9. PubMed ID: 2935737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
    Johnston GD; Vyssoulis G; Feely J; Holden RD; Radley DR
    J Hum Hypertens; 1995 Feb; 9(2):123-9. PubMed ID: 7752174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of low dose metoprolol CR/ZOK in mild hypertension and in elderly patients with mild to moderate hypertension.
    Jäättelä A; Baandrup S; Houtzagers J; Westergren G
    J Clin Pharmacol; 1990 Feb; 30(S2):S66-71. PubMed ID: 2179283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systolic time intervals as possible predictors of pressure response to sustained beta-adrenergic blockade in arterial hypertension. A within-patient, placebo-controlled study.
    Verdecchia P; Brignole M; Delfino G; Queirolo C; De Marchi G; Bertulla A
    Hypertension; 1983; 5(1):140-6. PubMed ID: 6336719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effect of diet compared with drug treatment in obese men with mild hypertension.
    Berglund A; Andersson OK; Berglund G; Fagerberg B
    BMJ; 1989 Aug; 299(6697):480-5. PubMed ID: 2507028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension.
    Gall MA; Rossing P; Skøtt P; Hommel E; Mathiesen ER; Gerdes LU; Lauritzen M; Vølund A; Faergeman O; Beck-Nielsen H
    Am J Hypertens; 1992 May; 5(5 Pt 1):257-65. PubMed ID: 1581012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol.
    Cruickshank JK; Anderson NM; Wadsworth J; Young SM; Jepson E
    BMJ; 1988 Nov; 297(6657):1155-9. PubMed ID: 3144329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of antihypertensive efficacy of lisinopril compared to metoprolol in moderate to severe hypertension.
    Zachariah PK; Bonnet G; Chrysant SG; DeBacker G; Goldstein R; Herrera J; Lindner A; Materson BJ; Maxwell MH; McMahon FG
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S53-8. PubMed ID: 2442553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.
    Pollare T; Lithell H; Selinus I; Berne C
    BMJ; 1989 Apr; 298(6681):1152-7. PubMed ID: 2500169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.
    Scholze J; Grimm E; Herrmann D; Unger T; Kintscher U
    Circulation; 2007 Apr; 115(15):1991-8. PubMed ID: 17404163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
    Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension, exercise, and beta-adrenergic blockade.
    Ades PA; Gunther PG; Meacham CP; Handy MA; LeWinter MM
    Ann Intern Med; 1988 Oct; 109(8):629-34. PubMed ID: 2901818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity as a determinant for response to antihypertensive treatment.
    Schmieder RE; Gatzka C; Schächinger H; Schobel H; Rüddel H
    BMJ; 1993 Aug; 307(6903):537-40. PubMed ID: 8400973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial.
    Erwteman TM; Nagelkerke N; Lubsen J; Koster M; Dunning AJ
    Br Med J (Clin Res Ed); 1984 Aug; 289(6442):406-9. PubMed ID: 6432119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.